Modulation of Neutrophil Activity by Soluble Complement Cleavage Products-An In-Depth Analysis

Cells. 2022 Oct 20;11(20):3297. doi: 10.3390/cells11203297.

Abstract

The cellular and fluid phase-innate immune responses of many diseases predominantly involve activated neutrophil granulocytes and complement factors. However, a comparative systematic analysis of the early impact of key soluble complement cleavage products, including anaphylatoxins, on neutrophil granulocyte function is lacking. Neutrophil activity was monitored by flow cytometry regarding cellular (electro-)physiology, cellular activity, and changes in the surface expression of activation markers. The study revealed no major effects induced by C3a or C4a on neutrophil functions. By contrast, exposure to C5a or C5a des-Arg stimulated neutrophil activity as reflected in changes in membrane potential, intracellular pH, glucose uptake, and cellular size. Similarly, C5a and C5a des-Arg but no other monitored complement cleavage product enhanced phagocytosis and reactive oxygen species generation. C5a and C5a des-Arg also altered the neutrophil surface expression of several complement receptors and neutrophil activation markers, including C5aR1, CD62L, CD10, and CD11b, among others. In addition, a detailed characterization of the C5a-induced effects was performed with a time resolution of seconds. The multiparametric response of neutrophils was further analyzed by a principal component analysis, revealing CD11b, CD10, and CD16 to be key surrogates of the C5a-induced effects. Overall, we provide a comprehensive insight into the very early interactions of neutrophil granulocytes with activated complement split products and the resulting neutrophil activity. The results provide a basis for a better and, importantly, time-resolved and multiparametric understanding of neutrophil-related (patho-)physiologies.

Keywords: anaphylatoxins; complement system; inflammation; innate immunity; neutrophils.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anaphylatoxins* / analysis
  • Anaphylatoxins* / pharmacology
  • Complement C5a, des-Arginine
  • Complement System Proteins
  • Glucose
  • Neutrophils*
  • Reactive Oxygen Species

Substances

  • Complement C5a, des-Arginine
  • Reactive Oxygen Species
  • Anaphylatoxins
  • Complement System Proteins
  • Glucose

Grants and funding

This research was funded by a research grant (“Forum Gesundheitsstandort”) from the Ministry of Science, Research, and Art Baden-Wuerttemberg to D.A.C.M. and M.H.-L., and a “Gerok Rotation” (rotation as clinician scientist) to D.A.C.M. by the Collaborative Research Center 1149 (project number 251293561), German Research Foundation. The funders had no role in the design of this study, data collection or interpretation, or the decision to submit results.